Strategy of following voriconazole versus amphoterian B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome

Thomas F. Patterson, Helen W. Boucher, Raoul Herbrecht, David W. Denning, Olivier Lortholary, Patricia Ribaud, Robert H. Rubin, John R. Wingard, Ben DePauw, Haran T. Schlamm, Peter Troke, John E. Bennett

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Strategy of following voriconazole versus amphoterian B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology